HKSE · 8372.HK
Grand Brilliance Group Holdings Limited
HK$0.17+HK$0.00 (+0.61%)
Grand Brilliance Group Holdings Limited’s quoted price sits in the upper half of its reported 52-week range, 7.78% below the high.
Loading market information…
HKSE · 0911.HK · HKD
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 05:17 AM UTC. Cached market data; not a live quote.
One-year closing-price history · HKD. Historical prices are not a forecast.
Qianhai Health Holdings Limited’s quoted price sits in the lower half of its reported 52-week range, 77.5% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Qianhai Health Holdings Limited’s forward annual dividend is HK$9.60 per share, paid quarterly. The forward yield is 3,047.62% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Qianhai Health Holdings Limited’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Qianhai Health Holdings Limited (0911.HK) functions as an investment holding company primarily focused on the distribution of health products and electronic components within Hong Kong. Its operations are structured into two main divisions: Health-Care Products and Electronic Component Products. The Health-Care Products segment supplies a range of items, including Chinese herbal medicines, various skincare and wellness products, and American ginseng, catering to both wholesale and retail clients. Concurrently, the Electronic Component Products division deals in items such as central processing units (CPUs) and semiconductors. Beyond these primary sales, the company also engages in the trading of both its health-care and electronic component offerings, alongside a money lending business. Established in 1989, the company underwent a name change in September 2016 from its previous identity, Hang Fat Ginseng Holdings Company Limited. It is headquartered in Sheung Wan, Hong Kong, and operates as a subsidiary of Explorer Rosy Limited.
Latest available per-share figures in HKD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 05:51 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
HK$0.17+HK$0.00 (+0.61%)
Grand Brilliance Group Holdings Limited’s quoted price sits in the upper half of its reported 52-week range, 7.78% below the high.
HK$0.23-HK$0.00 (-0.86%)
PuraPharm Corporation Limited’s quoted price sits in the lower half of its reported 52-week range, 47.73% below the high.
HK$0.11+HK$0.01 (+7.92%)
Wanjia Group Holdings Limited’s quoted price sits in the lower half of its reported 52-week range, 47.85% below the high.
HK$0.11-HK$0.01 (-5.88%)
Raily Aesthetic Medicine International Holdings Limited’s quoted price sits in the lower half of its reported 52-week range, 42.86% below the high.
HK$0.15-HK$0.00 (-0.65%)
Medicskin Holdings Limited’s quoted price sits in the upper half of its reported 52-week range, 24.0% below the high.
HK$0.06-HK$0.00 (-1.61%)
Elegance Optical International Holdings Limited’s quoted price sits in the lower half of its reported 52-week range, 64.12% below the high.
HK$0.02-HK$0.00 (-10.0%)
Pa Shun International Holdings Limited’s quoted price sits in the lower half of its reported 52-week range, 77.5% below the high.
HK$0.37-HK$0.01 (-1.35%)
MaxWin International Holdings Limited’s quoted price sits in the lower half of its reported 52-week range, 76.75% below the high.
